Stock Based Compensation (Tables)

6 Months Ended

Jun. 30, 2020

Share-based Payment Arrangement [Abstract]

Schedule of stock-based compensation expense stock options and restricted stock

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020		Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Research and development	$	43,605	$	43,605	$	—	$	—
General and administrative		251,751		677,595		486,396		607,622
	$	295,356	$	721,200	$	486,396	$	607,622

Schedule of fair value of employee stock options

	Six Months Ended June 30, 2020
Weighted average exercise price	$	5.18
Weighted average grant date fair value	$	4.02
Assumptions
Expected volatility		87-90	%
Expected terms (in years)		6.3-10
Risk-free interest rate		0.43-1.47	%
Expected dividend yield		0.00	%

Schedule of stock option activity

	Number of Shares			Weighted- Average Exercise Prices		Weighted- Average Remaining Contractual Term (In Years)		Intrinsic Value
Outstanding at January 1, 2020		2,139,078		$	3.46		9.17	$	4,052,512
Granted		182,255			5.18		—		—
Cancelled		(20,000	)		5.24		—		—
Outstanding at June 30, 2020		2,301,333		$	3.58		8.75	$	5,027,263
Exercisable at June 30, 2020		681,381		$	2.50		8.13	$	2,219,552